Symbicort SMART Satisfaction From Patient Perspective 2009

AstraZeneca

Status: Completed

Conditions: Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT00946452

NIS-RMY-SYM-2009/1

Details and patient eligibility

About

To characterize the level of asthma control and patient satisfaction amongst diagnosed asthma sufferers who are currently receiving Symbicort Maintenance and Reliever Therapy (SMART) in Malaysia.

Enrollment: 205 patients

Sex: All

Ages: 18 to 59 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have been prescribed Symbicort SMART (1 or 2 inhalation twice daily) by their Dr's for the past 3 months
• Informed consent

Exclusion criteria

• Symbicort SMART treatment < 3 months
• Patients requiring short courses of oral steroids more than twice in a month